$ARTV
Artiva Biotherapeutics (ARTV) Insider Trading
Artiva Biotherapeutics, Inc.Micro Cap$206M
Insiders bought $109.0M of Artiva Biotherapeutics stock in the last 12 months, led by RA Capital Management among 2 buyers, against $2.8M of sales.
View trades →
Insiders (12-Month)
7 Insiders
View trades →
Insider Buys (12-Month)
+$109.0M
2 insiders · 10 buys
Latest Buy
Jul 31, 2026
RA Capital Management, L.P. · $456K
Politicians (12-Month)
No politician trades
Recent Insider Trades in ARTV
| Type | Insider | Role | Price | Shares | ΔOwn | Value | Filed |
|---|---|---|---|---|---|---|---|
SELL | Horan Christopher | Chief Tech Operations Officer | $4.18 | 10,423 | −3.3% | -$43,580 | 1d ago |
SELL | Bush Jennifer | COO, CLO, Compliance Officer | $4.18 | 8,439 | −2.3% | -$35,284 | 1d ago |
SELL | Aslan Fred | CEO | $4.18 | 62,178 | −4.1% | -$259,972 | 1d ago |
SELL10b5-1 | Aslan Fred | CEO | $7.20 | 23,463 | −1.5% | -$168,880 | Oct 7, '26 |
SELL | Horan Christopher | Chief Tech Operations Officer | $6.84 | 10,340 | −3.2% | -$70,697 | Oct 6, '26 |
SELL | Aslan Fred | CEO | $6.84 | 61,696 | −3.8% | -$421,828 | Oct 6, '26 |
SELL | Bush Jennifer | COO, CLO, Compliance Officer | $6.84 | 8,370 | −2.2% | -$57,227 | Oct 6, '26 |
SELL10b5-1 | Aslan Fred | CEO | $10.92 | 23,429 | −1.6% | -$255,746 | Sep 9, '26 |
SELL | Horan Christopher | Chief Tech Operations Officer | $11.16 | 10,366 | −3.5% | -$115,638 | Sep 4, '26 |
SELL | Bush Jennifer | COO, CLO, Compliance Officer | $11.16 | 8,391 | −2.5% | -$93,606 | Sep 4, '26 |
SELL | Banerjee Subhashis | CMO | $11.16 | 1,100 | −0.8% | -$12,271 | Sep 4, '26 |
SELL | Aslan Fred | CEO | $11.16 | 61,888 | −4.0% | -$690,392 | Sep 4, '26 |
SELLOE+Sale10b5-1 | Banerjee Subhashis | CMO | $12.01 | 8,222 | −5.5% | -$98,736 | Aug 31, '26 |
BUY | RA Capital Management, L.P. | Director | $9.96 | 45,768 | +0.1% | +$455,726 | Jul 31, '26 |
BUY | RA Capital Management, L.P. | Director | $9.99 | 41,319 | +0.2% | +$412,777 | Jul 28, '26 |
BUY | RA Capital Management, L.P. | Director | $9.76 | 264,586 | +1.5% | 🐋 +$2,583,314 | Jul 23, '26 |
BUY | RA Capital Management, L.P. | Director | $8.93 | 160,354 | +0.9% | 🐋 +$1,432,119 | Jul 20, '26 |
BUY | RA Capital Management, L.P. | Director | $8.94 | 6,522 | +<0.1% | +$58,307 | Jul 14, '26 |
BUY | RA Capital Management, L.P. | Director | $8.89 | 32,876 | +0.2% | +$292,126 | Jun 29, '26 |
BUY | RA Capital Management, L.P. | Director | $8.66 | 531,326 | +3.1% | 🐋 +$4,599,903 | Jun 16, '26 |
BUY | RA Capital Management, L.P. | Director | $7.44 | 1,027,722 | +6.3% | 🐋 +$7,650,148 | Jun 11, '26 |
BUY | GC Corp. | 10% Owner | $11.52 | 1,432,291 | +31.4% | 🐋 +$16,499,992 | May 28, '26 |
SELL | Raymon Heather | SVP, Research & Development | $9.01 | 3,095 | −2.0% | -$27,879 | May 20, '26 |
SELL | Horan Christopher | Chief Tech Operations Officer | $9.01 | 7,002 | −2.3% | -$63,073 | May 20, '26 |
SELL | Bush Jennifer | COO, CLO, Compliance Officer | $9.01 | 8,790 | −2.5% | -$79,179 | May 20, '26 |
SELL | Banerjee Subhashis | CMO | $9.01 | 7,037 | −4.6% | -$63,386 | May 20, '26 |
SELL | Aslan Fred | CEO | $9.01 | 27,116 | −1.7% | -$244,253 | May 20, '26 |
BUY | RA Capital Management, L.P. | Director | $11.52 | 6,510,416 | +66.1% | 🐋 +$74,999,992 | May 13, '26 |
SELL10b5-1 | Aslan Fred | President & CEO | $6.00 | 3,187 | −0.3% | -$19,122 | Dec 16, '25 |
SELL10b5-1 | Aslan Fred | President & CEO | $3.38 | 6,375 | −1.8% | -$21,522 | Nov 18, '25 |
Older than 12 months | |||||||
SELL10b5-1 | Aslan Fred | President & CEO | $6.00 | 25,500 | −6.7% | -$153,000 | Oct 18, '25 |
SELL10b5-1 | Aslan Fred | President & CEO | $2.73 | 25,500 | −6.3% | -$69,579 | Aug 19, '25 |